Understanding minimum and ideal factor levels for participation in physical activities by people with haemophilia: An expert elicitation exercise
Author:
Affiliation:
1. HCD Economics Daresbury UK
2. Faculty of Health and Social Care University of Chester Chester UK
Funder
Takeda Pharmaceuticals North America
Publisher
Wiley
Subject
Genetics (clinical),Hematology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13985
Reference21 articles.
1. Guidelines for the management of hemophilia
2. Clotting factor concentrates given to prevent bleeding and bleeding‐related complications in people with hemophilia A or B;Iorio A;Cochrane Database Syst Rev,2011
3. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
4. A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management
5. Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective Study;Journal of Clinical Medicine;2024-03-06
2. Machine learning model for predicting physical activity related bleeding risk in Chinese boys with haemophilia A;Thrombosis Research;2023-12
3. Targeting higher factor VIII levels for prophylaxis in haemophilia A: a narrative review;Haemophilia;2023-09-27
4. Additional Relevant Measure on Bleeding Among Patients With Hemophilia A. Comment on “Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study” (Preprint);JMIR Public Health and Surveillance;2023-07-29
5. “Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients with Hemophilia A in China: Discrete Choice Experiment Study”: comments from Huang et al. (Preprint);2023-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3